Patrick John Finn Ph.D.
Net Worth
Last updated:
What is Patrick John Finn Ph.D. net worth?
The estimated net worth of Dr. Patrick John Finn Ph.D. is at least $15,624,027 as of 11 Nov 2024. He owns shares worth $6,285,206 as insider, has earned $4,980,721 from insider trading and has received compensation worth at least $4,358,100 in Twist Bioscience Corporation.
What is the salary of Patrick John Finn Ph.D.?
Dr. Patrick John Finn Ph.D. salary is $726,350 per year as Chief Commercial Officer in Twist Bioscience Corporation.
How old is Patrick John Finn Ph.D.?
Dr. Patrick John Finn Ph.D. is 53 years old, born in 1972.
What stocks does Patrick John Finn Ph.D. currently own?
As insider, Dr. Patrick John Finn Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Twist Bioscience Corporation (TWST) | Chief Commercial Officer | 221,061 | $28.43 | $6,285,206 |
What does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Patrick John Finn Ph.D. insider trading
Twist Bioscience Corporation
Dr. Patrick John Finn Ph.D. has made 44 insider trades between 2019-2024, according to the Form 4 filled with the SEC. Most recently he sold 10,340 units of TWST stock worth $496,299 on 11 Nov 2024.
The largest trade he's ever made was exercising 36,932 units of TWST stock on 27 Nov 2019. As of 11 Nov 2024 he still owns at least 221,061 units of TWST stock.
Twist Bioscience key executives
Twist Bioscience Corporation executives and other stock owners filed with the SEC:
- Dr. Emily Marine Leproust Ph.D. (52) Co-Founder, Chairman, Pres & Chief Executive Officer
- Dr. Patrick John Finn Ph.D. (53) Chief Commercial Officer
- Dr. William Charles Banyai Ph.D. (70) Senior Vice President of Advanced Devel., GM of Data Storage & Director
- Mr. James M. Thorburn (69) Chief Financial Officer
- Mr. Patrick Weiss (54) Chief Operating Officer